Mixed axonal-demyelinating: Most common pattern in chronic polyneuropathies
In 2001, we invested 30 millions to precede GMP construction, In 2004, we passed GMP dynamic authentication and are the first to reach international advanced level in the same industry
By targeting two pathways instead of one, research suggests it may offer a robust approach to weight management and metabolic health
This selective mechanism of action means that the compound could potentially improve metabolic health, enhance energy levels, and support sustainable weight management without the harsh side effects often associated with other metabolic enhancers
Previous studies have reported inconsistent results when comparing oral, sublingual, and intramuscular administration, often limited by small sample sizes or heterogeneous populations (Houle et al., 2014